Cargando…
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9
BACKGROUND: Prognosis of patients with colorectal cancer liver metastasis (CRCLM) is estimated based on clinicopathological models. Stratifying patients based on tumor biology may have additional value. METHODS: Tissue micro-arrays (TMAs), containing resected CRCLM and corresponding primary tumors f...
Autores principales: | Goos, Jeroen A.C.M., Coupé, Veerle M.H., van de Wiel, Mark A., Diosdado, Begoña, Delis-Van Diemen, Pien M., Hiemstra, Annemieke C., de Cuba, Erienne M.V., Beliën, Jeroen A.M., Menke - van der Houven van Oordt, C. Willemien, Geldof, Albert A., Meijer, Gerrit A., Hoekstra, Otto S., Fijneman, Remond J.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811521/ https://www.ncbi.nlm.nih.gov/pubmed/26497206 |
Ejemplares similares
-
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014) -
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013) -
Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
por: de Wit, Meike, et al.
Publicado: (2017) -
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
por: Nugteren, Sandrine, et al.
Publicado: (2020) -
Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)